First Time Loading...

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 331.66 USD 0.93% Market Closed
Updated: May 25, 2024

West Pharmaceutical Services Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

West Pharmaceutical Services Inc
Operating Income Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
West Pharmaceutical Services Inc
NYSE:WST
Operating Income
$661.6m
CAGR 3-Years
9%
CAGR 5-Years
20%
CAGR 10-Years
15%
Thermo Fisher Scientific Inc
NYSE:TMO
Operating Income
$7.3B
CAGR 3-Years
-10%
CAGR 5-Years
13%
CAGR 10-Years
16%
Danaher Corp
NYSE:DHR
Operating Income
$9.5B
CAGR 3-Years
20%
CAGR 5-Years
26%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Operating Income
$1.1B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Operating Income
$1.3B
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
16%
IQVIA Holdings Inc
NYSE:IQV
Operating Income
$2.1B
CAGR 3-Years
38%
CAGR 5-Years
21%
CAGR 10-Years
16%

See Also

What is West Pharmaceutical Services Inc's Operating Income?
Operating Income
661.6m USD

Based on the financial report for Mar 31, 2024, West Pharmaceutical Services Inc's Operating Income amounts to 661.6m USD.

What is West Pharmaceutical Services Inc's Operating Income growth rate?
Operating Income CAGR 10Y
15%

Over the last year, the Operating Income growth was -10%. The average annual Operating Income growth rates for West Pharmaceutical Services Inc have been 9% over the past three years , 20% over the past five years , and 15% over the past ten years .